Wheat allergy: clinical and laboratory findings. 2004

Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran. zpourpak@hbi.ir

BACKGROUND Food allergy affects 6-8% of infants and wheat allergy is one of the common food allergies among children. The clinical and laboratory manifestations of wheat allergy were evaluated in this study. METHODS Thirty-two children (< or =12 years old) with suspected wheat allergy were evaluated for wheat allergy. The patients underwent wheat skin prick test (SPT), measurement of wheat-specific IgE and wheat challenge test. The patients with a convincing history of anaphylaxis following ingestion of wheat or with a positive challenge test, and those with a history of immediate hypersensitivity reaction following ingestion of wheat in addition to a positive wheat SPT and/or positive wheat-specific IgE were considered wheat allergic. Then, the laboratory and clinical manifestations of their disease were studied. RESULTS Among patients with suspected wheat allergy, 24 patients with definite wheat allergy were identified. Anaphylaxis was a dominant clinical feature, accounting for 54.1% of acute symptoms. Chronic allergy symptoms like asthma and eczema were noted in 50% of the patients. Wheat-specific IgE was higher in patients with anaphylaxis (p<0.02) and the risk of anaphylaxis was 14.4 times more in patients with wheat-specific IgE equal to or more than 3+. CONCLUSIONS Anaphylaxis had occurred in a remarkable number of patients repeatedly, which demonstrates the severity of the reactions, poor knowledge of the disease and probable existence of more patients with mild reactions. Regarding the higher level of wheat-specific IgE in patients with anaphylaxis, wheat-specific IgE could be used to predict the severity of symptoms.

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004802 Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. Eosinophilia, Tropical,Hypereosinophilia,Tropical Eosinophilia,Hypereosinophilias,Tropical Eosinophilias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000707 Anaphylaxis An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death. Anaphylactic Reaction,Anaphylactoid Reaction,Anaphylactoid Shock,Shock, Anaphylactic,Anaphylactic Reactions,Anaphylactic Shock,Anaphylactoid Reactions,Reaction, Anaphylactic,Reaction, Anaphylactoid,Shock, Anaphylactoid

Related Publications

Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
January 2003, Acta dermatovenerologica Croatica : ADC,
Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
October 2016, Korean journal of pediatrics,
Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
January 2016, Expert review of clinical immunology,
Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
September 1968, Proceedings of the Royal Society of Medicine,
Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
October 1974, Nihon Jibiinkoka Gakkai kaiho,
Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
November 2022, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
June 2009, Current opinion in allergy and clinical immunology,
Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
January 2020, Journal of Korean medical science,
Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
December 1989, Current opinion in oncology,
Zahra Pourpak, and Mahboubeh Mansouri, and Mehrnaz Mesdaghi, and Anoushiravan Kazemnejad, and Abolhasan Farhoudi
October 1965, Archives of internal medicine,
Copied contents to your clipboard!